Edwards Lifesciences Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $594.4M | $4.15B | $1.18B |
| FY2020 | $595.0M | $4.57B | $1.18B |
| FY2021 | $595.7M | $5.84B | $862.8M |
| FY2022 | $596.3M | $5.81B | $769.0M |
| FY2023 | $597.0M | $6.65B | $1.13B |